Almouneer is a technology company.
Almouneer has raised $4.0M across 1 funding round.
Almouneer has raised $4.0M in total across 1 funding round.
Almouneer has raised $4.0M in total across 1 funding round.
Almouneer's investors include Global Ventures, Khalid AlNasser, Raed Marouf.
Almouneer is an Egyptian healthtech company building a digital platform to manage chronic diseases like diabetes and obesity. It connects patients with doctors, health coaches, labs, and nutritionists via its DRU app, a lifestyle and health management tool that includes practice management software for providers—covering electronic medical records, booking, and financial systems—while taking a cut from referral fees and planning a marketplace for consumables like glucose monitors.[1][2][3][5]
The platform serves patients with diabetes, prediabetes, and obesity in Egypt, solving access issues to integrated care in regions with high chronic disease burdens by enabling seamless provider networking and operational support for external clinics. After raising $3.6M in seed funding in 2023, Almouneer is scaling the DRU app, expanding its provider ecosystem, and targeting growth in Saudi Arabia, UAE, Nigeria, and Kenya.[1][2]
Almouneer was founded in 2017 by Noha Khater (CEO, an ophthalmologist trained in the U.S. in the early 2000s) and Rania Kadry (CTO), starting as tech-enabled clinics focused on ophthalmology, inspired by Khater's experience with superior U.S. healthcare systems emphasizing patient data access and provider communication.[1][2][6]
The idea evolved from Khater's firsthand observations as a physician; it pivoted from physical clinics treating diabetes-related eye diseases to a software-driven model supporting external providers for chronic care, launching the DRU app for broader diabetes and obesity management. Early traction came from operational clinic success, leading to the 2023 $3.6M seed round to fuel app adoption and talent hires.[1][5]
Almouneer rides the digital health wave in emerging markets, where diabetes/obesity rates are surging—Egypt faces high prevalence amid limited infrastructure—by digitizing fragmented care via apps and SaaS for providers.[1][4] Timing aligns with post-pandemic telehealth adoption and MENA/Africa's healthtech funding boom, amplified by investor interest in scalable chronic disease platforms amid aging populations and urbanization.[1][2]
Market forces like rising smartphone penetration and demand for affordable management tools favor it, positioning Almouneer to influence Egypt's ecosystem by standardizing provider ops and enabling cross-border scaling, much like how early pivots in healthtech (e.g., from clinics to software) have disrupted traditional care in similar regions.[6]
Almouneer is poised for multi-market expansion post-2023 funding, prioritizing DRU app rollout, provider growth, and marketplace launch while entering Saudi Arabia, UAE, Nigeria, and Kenya—potentially capturing shares in high-diabetes regions.[1] Trends like AI-driven personalization in chronic care and regulatory pushes for digital health in MENA/Africa will shape its path, evolving its influence from Egypt's clinic digitizer to a regional platform leader.
This builds on its clinic-to-software pivot, revolutionizing access for millions grappling with diabetes and obesity.[1][2]
Almouneer has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in October 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2023 | $4.0M Seed | Global Ventures, Khalid AlNasser, Raed Marouf |